|
Watzlawik, Jens O; Painter, Meghan M; Wootla, Bharath et al. (2015) A human anti-polysialic acid antibody as a potential treatment to improve function in multiple sclerosis patients. J Nat Sci 1:
|
|
Paz Soldán, M Mateo; Novotna, Martina; Abou Zeid, Nuhad et al. (2015) Relapses and disability accumulation in progressive multiple sclerosis. Neurology 84:81-8
|
|
Perschbacher, Katherine; Smestad, John A; Peters, Justin P et al. (2015) Quantitative PCR analysis of DNA aptamer pharmacokinetics in mice. Nucleic Acid Ther 25:11-9
|
|
Wootla, Bharath; Denic, Aleksandar; Rodriguez, Moses (2014) Polyclonal and monoclonal antibodies in clinic. Methods Mol Biol 1060:79-110
|
|
Waubant, Emmanuelle; Mowry, Ellen M; Krupp, Lauren et al. (2013) Antibody response to common viruses and human leukocyte antigen-DRB1 in pediatric multiple sclerosis. Mult Scler 19:891-5
|
|
Tutuncu, Melih; Tang, Junger; Zeid, Nuhad Abou et al. (2013) Onset of progressive phase is an age-dependent clinical milestone in multiple sclerosis. Mult Scler 19:188-98
|
|
Xu, Xiaohua; Denic, Aleksandar; Warrington, Arthur E et al. (2013) Therapeutics to promote CNS repair: a natural human neuron-binding IgM regulates membrane-raft dynamics and improves motility in a mouse model of multiple sclerosis. J Clin Immunol 33 Suppl 1:S50-6
|
|
Watzlawik, Jens O; Warrington, Arthur E; Rodriguez, Moses (2013) PDGF is required for remyelination-promoting IgM stimulation of oligodendrocyte progenitor cell proliferation. PLoS One 8:e55149
|
|
Lee, Moonnoh R; Denic, Aleksandar; Hinton, David J et al. (2012) Preclinical (1)H-MRS neurochemical profiling in neurological and psychiatric disorders. Bioanalysis 4:1787-804
|
|
Warrington, Arthur E; Van Keulen, Virginia; Pease, Larry R et al. (2012) Naturally occurring antibodies as therapeutics for neurologic disease: can human monoclonal IgMs replace the limited resource IVIG? Adv Exp Med Biol 750:44-55
|
Showing the most recent 10 out of 145 publications
